Found 39 matching trials
Implementation Study of Treatment Optimization Recommendations on Relapsing-Remitting Multiple Sclerosis (RR MS) Subjects PHASE4 Brief Summary: 800 RRMS Subjects currently treated with Avonex or Copaxone ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®. PHASE4 This study is designed to compare injection site reactions with or without ...
Show More Location
Multiple Locations
Learn More & Join Trial
Patients With Relapse Remitting Multiple Sclerosis (RRMS): Candidates for MS Therapy Change PHASE4 The purpose of this study is to evaluate the change in patient-reported tre...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
A Prospective Study of Spasticity in Individuals With Multiple Sclerosis N/A This study is expected to contribute to the body of knowledge on the benefi...
Show More Location
Shared Solutions Call Center
Learn More & Join Trial
BEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New Dose PHASE3 The BEYOND Follow-Up study will give patients who participated in the prece...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Effectiveness of Cinnomer® (Glatiramer Acetate) in Multiple Sclerosis (MS) Treatment in Iran N/A This trial was an obsevational phase IV prospective multicenter study desig...
Show More Location
Multiple Locations
Learn More & Join Trial
Study to Assess Medication Satisfaction in Patients With Relapsing Remitting Multiple Sclerosis Treated With Copaxone® PHASE4 The primary objective of this study is to compare patient medication satisf...
Show More Location
Teva Investigational Site 13485
Learn More & Join Trial
Glatiramer Acetate (Copaxone®) Study to Follow Participants From the First Original Study for Safety and Effectiveness PHASE4 This open-label extension study will evaluate the long-term safety of glati...
Show More Location
Teva Investigational Site 009
Learn More & Join Trial
A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®. PHASE4 This study is designed to compare injection skin (injection site) reactions...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis PHASE3 To determine if treatment with BG00012 can decrease the number of MS relaps...
Show More Learn More & Join Trial